Congo Wants More Use of Merck Vaccine Rather Than J&J Newcomer: Minister

May 22, 2019

(Reuters) – Democratic Republic of Congo called on Wednesday for Merck’s experimental Ebola vaccine to be fully licensed to facilitate its use in the Ebola-hit country, while saying Johnson & Johnson’s rival drug would complicate matters. Both vaccines are experimental drugs that can be used under strictly controlled research protocols but Merck’s has been used throughout the outbreak and has proven highly effective, the World Health Organization (WHO) says.

Recommended Reading